'180 Life Sciences', Listed in the US, Plans to Raise $100 Million to Accumulate Ethereum
Son Min
Summary
- '180 Life Sciences' announced a fundraising plan to accumulate Ethereum (ETH).
- They stated an intention to issue senior secured convertible bonds worth $156 million to institutional investors in order to purchase additional Ethereum.
- McAndrew Rudisill, Chairman of the Board, said that this fundraising will help strengthen their financial soundness.
Nasdaq-listed '180 Life Sciences' has announced a fundraising plan to accumulate Ethereum (ETH).
According to PR Newswire on the 11th (local time), '180 Life Sciences' stated in a press release, "We plan to issue senior secured convertible bonds worth $156 million to institutional investors," and "With the funds raised, we intend to additionally purchase Ethereum."
McAndrew Rudisill, Chairman of the Board, said, "Through this convertible bond issuance, we aim to accumulate Ethereum. This will further strengthen our company's financial soundness."
Son Min
sonmin@bloomingbit.ioHello I’m Son Min, a journalist at BloomingBit
![[Analysis] "XRP risks repeating the 2022 rout…most short-term investors in the red"](https://media.bloomingbit.io/PROD/news/845f37bb-29b4-4bc5-9e10-8cafe305a92f.webp?w=250)
![[Exclusive] “Airdrops also taxable”... Authorities to adopt a ‘comprehensive approach’ to virtual assets](https://media.bloomingbit.io/PROD/news/4bde9dab-09bd-4214-a61e-f6dbf5aacdfb.webp?w=250)